Isolation of Mycobacterium thermoresistibile following augmentation mammaplasty.
This is the first case report of a Mycobacterium thermoresistibile infection following augmentation mammaplasty and is the fourth human case report of M. thermoresistibile infection. Antimicrobial susceptibility results determined by a modified proportion method using a 3-day incubation were the same as those determined by the standard 3-week assay.
Wolfe
J M
JM
Public Health Laboratory, Orange County Health Care Administration, Santa Ana, California 92706.
Moore
D F
DF
D000328:Adult; D000900:Anti-Bacterial Agents; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016462:Mammaplasty / Q000009:adverse effects*; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy / Q000209:etiology*; D009170:Nontuberculous Mycobacteria / Q000187:drug effects / Q000302:isolation & purification*; D012293:Rifampin / Q000627:therapeutic use; D013530:Surgical Wound Infection / Q000188:drug therapy / Q000209:etiology*
D000900:Anti-Bacterial Agents; D004977:Ethambutol; D012293:Rifampin